ROYAL BANK OF CANADA - JUNIPER PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$0250.0%0.00%
Q1 2018$0
-100.0%
25
-96.2%
0.00%
Q4 2017$3,000
-90.3%
651
-90.6%
0.00%
Q3 2017$31,000
-11.4%
6,901
+0.4%
0.00%
Q2 2017$35,000
+6.1%
6,875
-0.5%
0.00%
Q1 2017$33,000
-15.4%
6,912
+0.5%
0.00%
Q4 2016$39,000
+2.6%
6,8750.0%0.00%
Q3 2016$38,000
-22.4%
6,875
-1.3%
0.00%
Q2 2016$49,000
+6.5%
6,9650.0%0.00%
Q1 2016$46,000
-59.3%
6,965
-36.5%
0.00%
Q4 2015$113,000
-13.1%
10,965
-0.5%
0.00%
Q3 2015$130,000
+28.7%
11,0200.0%0.00%
Q2 2015$101,00011,0200.00%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 328,132$1,821,0001.25%
Stonepine Capital Management, LLC 173,967$966,0000.79%
Krensavage Asset Management, LLC 288,294$1,600,0000.58%
ALGERT GLOBAL LLC 79,745$443,0000.13%
HEARTLAND ADVISORS INC 400,000$2,220,0000.13%
PERRITT CAPITAL MANAGEMENT INC 27,950$155,0000.04%
Spark Investment Management LLC 48,400$268,0000.02%
TFS CAPITAL LLC 14,707$82,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$1,000,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 36,210$201,0000.01%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders